ENRICHD and SADHART: Implications for future biobehavioral intervention efforts.

  • Sheps D
  • Freedland K
  • Golden R
 et al. 
  • 26

    Readers

    Mendeley users who have this article in their library.
  • 34

    Citations

    Citations of this article.

Abstract

Briefly discusses the results of the Enhancing Recovery in Coronary Heart Disease (ENRICHD) trial and the Sertraline Antidepressant Heart Attack Trial (SADHART) which have produced disappointment and concern. It is noted that the ENRICHD and SADHART depression outcomes fell short of expectation and the ENRICHD intervention failed to prolong reinfarction-free survival. The authors argue that researchers should not abandon this form of investigation but should instead set their sights on the appropriate design of future studies. (PsycINFO Database Record (c) 2012 APA, all rights reserved)

Author-supplied keywords

  • Coronary heart disease
  • ENRICHD trial
  • Experimentation
  • Heart Disorders
  • Heart attack
  • Recovery (Disorders)
  • SADHART
  • biobehavioral intervention
  • depression
  • drug therapy
  • early intervention
  • major depression
  • recovery
  • sertraline

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PUI: 36143191
  • SGR: 0037247937
  • PMID: 12554810
  • SCOPUS: 2-s2.0-0037247937
  • ISBN: 0033-3174
  • ISSN: 0033-3174

Authors

  • David S Sheps

  • Kenneth E Freedland

  • Robert N Golden

  • Robert P McMahon

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free